Your Partner in Drug Delivery Systems
PreclinApps develops cost-efficient, ethical sustained release systems for pharmaceuticals at Smart Chemistry Park, Finland.
Focused on developing and commercializing sustained release products and services for preclinical drug discovery markets, veterinary medication and clinical applications. Our MedRod® implant products have been used widely in preclinical animal R&D for hormone delivery.
Innovative Tools For Drug Delivery
MedRod® implants for in vivo research help you to implement 3R ethical principles in your laboratory and animal research. MedRod implants dose the drugs in very stable manner and thus will ensure the quality of your studies. MedRod system doses just the drug, nothing else to the target animal or tissue. No dissolving excipients are used in our system.
“Our broad expertise in drug development, formulation development, preclinical and medical R&D help you to develop high quality polymer-based drug delivery systems for clinical, veterinary and preclinical applications.”
Jukka Rissanen
What We provide
Do you know the drug release rate of your delivery system in use? Is it based on assumption or real measurements?
MedRod® implants designed for preclinical animal research.
Implants have been designed especially for supplementing tumor growth in hormone dependent cancer xenograft and PDX studies.
Contract Research Organization
PreclinApps can also serve as a contract research organization (CRO) and provide R&D services for pharmaceutical industry and other research institutes.
Consulting
PreclinApps can aid your research by guiding in the selection of animal model with suitable polymer and dosage selection. PreclinApps has decades of experience in animal research. We can also help you in designing long-term drug delivery systems for human use, including the material selection process and early feasibility studies including test sample manufacturing and dissolution studies.